THC
Tenet Healthcare Corp
$204.25
-2.52 (-1.22%)
At close · Jul 10
Market Cap
$17.59B
Shares
86,137,000
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$21.31B
+3.1%
FY2025
Net Income
$2.37B
-41.8%
FY2025
Operating Margin
16.46%
-12.4pp
FY2025
Diluted EPS
$15.49
-52.6%
FY2025
Operating Cash Flow
$3.54B
+72.9%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | $21.46B | $21.31B | $20.67B | $20.55B | $19.17B | $19.49B | $17.64B | $18.48B | $18.31B | — | — | — | — | — | — | — | — | |
| — | — | $166M | $172M | $174M | $172M | $188M | $172M | $188M | $185M | $172M | — | — | — | — | — | — | — | |
| — | $886M | $863M | $818M | $870M | $841M | $855M | $857M | $850M | $802M | $870M | $850M | $797M | $849M | $545M | $430M | $398M | $394M | |
| — | — | — | — | — | — | — | — | — | — | — | $3M | $6M | $3M | $16M | -$14M | $7M | — | |
| — | $3.86B | $3.51B | $5.96B | $2.51B | $2.33B | $2.87B | $1.99B | $1.51B | $1.65B | $1.11B | $1.22B | $1.06B | $925M | $663M | $749M | $653M | $634M | |
| — | — | 16.46% | 28.82% | 12.22% | 12.17% | 14.73% | 11.28% | 8.19% | 8.99% | — | — | — | — | — | — | — | — | |
| — | $4.75B | $4.37B | $6.77B | $3.38B | $3.17B | $3.73B | $2.85B | $2.36B | $2.45B | $1.98B | $2.07B | $1.85B | $1.77B | $1.21B | $1.18B | $1.05B | $1.03B | |
| — | $822M | $821M | $826M | $901M | $890M | $923M | $1B | $985M | $1B | $1.03B | $979M | $912M | $754M | $474M | $412M | $375M | $424M | |
| — | $132M | $117M | $126M | $19M | $10M | $14M | $1M | — | — | — | — | — | — | — | — | — | — | |
| — | $259M | $264M | $260M | $228M | $216M | $218M | $169M | $175M | $150M | $144M | $131M | $99M | $12M | $15M | $8M | $8M | — | |
| — | — | — | — | — | — | — | — | — | — | — | $8M | $1M | $1M | $1M | $1M | $3M | $5M | |
| — | $3.17B | $2.8B | $5.25B | $1.62B | $1.34B | $1.89B | $671M | $296M | $639M | -$101M | $248M | $144M | $147M | -$158M | $334M | $164M | — | |
| — | $516M | $433M | $1.18B | $306M | $344M | $411M | -$97M | $153M | $176M | $219M | $67M | $68M | $49M | -$65M | $125M | $61M | -$977M | |
| — | $2.65B | $2.37B | $4.06B | $1.31B | $1B | $1.48B | $768M | $154M | $466M | -$320M | $176M | $78M | $76M | -$104M | $133M | $94M | $1.12B | |
| — | — | 11.11% | 19.67% | 6.38% | 5.22% | 7.58% | 4.35% | 0.83% | 2.54% | — | — | — | — | — | — | — | — | |
| — | $948M | $960M | $864M | $700M | $590M | $562M | $369M | $386M | $355M | $384M | $368M | $218M | — | — | — | $12M | $9M | |
| — | $1.7B | $1.41B | $3.2B | $611M | $411M | $914M | $399M | -$232M | $111M | -$704M | -$192M | -$140M | $12M | -$134M | $141M | $58M | — | |
| — | $1.7B | $1.41B | $3.2B | $611M | $463M | $962M | $375M | -$266M | $135M | -$650M | -$286M | -$122M | -$146M | -$90M | $125M | $49M | $1.11B | |
| USD/shares | — | — | $15.61 | $33.02 | $6.01 | $3.84 | $8.55 | $3.80 | -$2.24 | $1.09 | -$7.00 | -$1.93 | -$1.41 | $0.12 | -$1.32 | $1.35 | $0.12 | $2.31 |
| USD/shares | $29.94 – $32.64 | — | $15.49 | $32.70 | $5.71 | $3.79 | $8.42 | $3.75 | -$2.24 | $1.07 | -$7.00 | -$1.93 | -$1.41 | $0.12 | -$1.32 | $1.30 | $0.12 | $2.04 |
| shares | — | — | 90.15M | 96.9M | 101.64M | 106.93M | 106.83M | 105.01M | 103.4M | 102.11M | 100.59M | 99.32M | 99.17M | 97.8M | 101.65M | 104.2M | 468.73M | 484.32M |
| shares | — | — | 90.83M | 97.88M | 104.8M | 110.52M | 108.57M | 106.26M | 103.4M | 103.88M | 100.59M | 99.32M | 99.17M | 100.29M | 101.65M | 108.93M | 485.18M | 560.63M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2011–FY2025: $3.99B in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Medical Care Facilities median 1.27×
EV/EBIT
—
Medical Care Facilities median 17.93×
P/E (TTM)
10.62×
Medical Care Facilities median 16.85×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Hospital Operations | $16,138,000,000 | $16,141,000,000 | $16,698,000,000 | $15,926,000,000 | $16,767,000,000 | $14,790,000,000 | $15,522,000,000 | $15,285,000,000 |
| Ambulatory Care | $5,172,000,000 | $4,534,000,000 | $3,866,000,000 | $3,248,000,000 | $2,718,000,000 | $2,072,000,000 | $2,158,000,000 | $2,085,000,000 |
| Conifer Segment | — | — | — | $1,316,000,000 | $1,267,000,000 | $1,306,000,000 | $1,372,000,000 | $1,533,000,000 |
| Core Services and Other Segment | — | — | — | — | — | — | $2,158,000,000 | $2,085,000,000 |
By Product & Service (USD)
| Component | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| Insurance Recoveries | $0 | $34,000,000 | $6,000,000 |